key: cord-0809008-ks4j7115
authors: Ansari, Mohammad Azam; Taha, Muhammad; Uddin, Nizam; Rahim, Fazal; Jamal, Qazi Mohammad Sajid; Alomary, Mohammad N.; Alshabrmi, Fahad M.; Almatroudi, Ahmad; Atwah, Banan; Alhindi, Zain; Iqbal, Naveed; Khan, Khalid Mohammed
title: Synthesis of indole-based oxadiazoles and their interaction with bacterial peptidoglycan and SARS-CoV-2 main protease: In vitro, molecular docking and in silico ADME/Tox study
date: 2022-04-09
journal: Journal of Saudi Chemical Society
DOI: 10.1016/j.jscs.2022.101474
sha: 2b9fcac9cdd755c5ab97205b7494f67301f1708f
doc_id: 809008
cord_uid: ks4j7115

In the present study, Indole-based-oxadiazole (1A-17A) compounds were successfully synthesized. The structures of all synthesized compounds were fully characterized by different sophisticated spectroscopic techniques such 1H NMR, 13C NMR, EI-MS and HREI-MS. Further, the synthesized compounds were explored to investigate their broad-spectrum antibacterial and antibiofilm potential against multidrug resistant Pseudomonas aeruginosa (MDR-PA) and methicillin resistant Staphylococcus aureus (MRSA). The compounds possessed a broad spectrum of antibacterial activity having MIC values of values 1-8 mg/ml against the tested microorganisms. Compound A6 and A7 shows maximum antibacterial activity against MDR-PA, whereas A6, A7 and A11 shows highest activity against MRSA. Furthermore, antibiofilm assay shows that A6, A7 and A11 showed maximum inhibition of biofilm formation and it was found that at 4 mg/ml; A6, A7 and A11 inhibit MRSA biofilm formation by 81.1, 77.5 and 75.9%, respectively; whereas in case of P. aeruginosa; A6 and A7 showed maximum biofilm inhibition and inhibit biofilm formation by 81.5 and 73.7%, respectively. Molecular docking study showed that compounds A6, A7, A8, A10, and A11 had high binding affinity to bacterial peptidoglycan, indicating their potential inhibitory activity against tested bacteria, whereas A6 and A11 were found to be the most effective inhibitors of SARS CoV-2 main protease (3CLpro), with a binding affinity of −7.78 kcal/mol. Furthermore, SwissADME and pkCSM-pharmacokinetics online tools was applied to calculate the ADME/Tox profile of the synthesized compounds and the toxicity of these chemicals was found to be low. The Lipinski, Veber, Ghose, and Consensus LogP criteria were also used to predict drug-likeness levels of the compounds. Our findings imply that the synthesized compounds could be a useful for the preventing and treating biofilm-related microbial infection as well as SARS-CoV2 infections.

The emergence and re-emergence of antimicrobial drug resistance due to their inappropriate and excessive use by a large number of disease-causing bacterial strains not only pose a great threat to the community health but also pose a challenge for the researchers to design and developed new antimicrobial drug (Desselberger 2000) . Regardless of presence of antibacterial therapy, the rate of disease and death associated with bacterial infections remain increasing, because of their ability to develop resistance to most of the present antibiotics (Ansari et al., 2012) . The infections caused by biofilm producing multidrug resistant bacterial strains such as Staphylococcus aureus and Pseudomonas aeruginosa are also a major threat because biofilm matrix obstructs the penetration of antibiotics inside the biofilm matrix (Ansari et al., 2014) . On the other hand, in December 2019 in Wuhan, China, a newly deadly emerged coronavirus strain has infected nearly the whole world's population that has produced an immediate urgency to discover promising targets for the treatment of COVID-19. As of February 2, 2022, 382,556,840confirmed COVID-19 cases and 5,707,556COVID-19-related deaths have been reported across the globe (https://www.worldometers.info/coronavirus/). In response to the COVID-19 pandemic, researchers have made significant progress in developing potential medical therapies. Several compounds are now being evaluated for their efficacy against COVID-19 illness, with some having progressed to clinical trials and others still in the preclinical phase (Missioui et al., 2022) . The nitrogen-containing heterocyclic compounds are reported to have far better activities (Akhtar et al., 2017; Barsoum et al., 2006; Kumar et al., 2009; Bandgar et al., 2012; Sundberg 1996; Singh 2014 ) than any other heteroatom compounds.

Indole is the bicyclic compound having nitrogen in five-member ring. Indole heterocycle is broadly spread in nature. The tryptophan and serotonin are found in numerous natural alkaloids which have indole ring as basic structure. Indole compounds reported to retain numerous biological and pharmacological activities and consequently have energized medicinal chemists for discovering them for additional research (Sharma et al., 2012) . Indole analogues displayed a large range of biological behaviors including anticancer (Mehndiratta et al., 2014) , antimicrobial (Liew et al., 2014) , anti-inflammatory (Yamuna et al., 2012) , antimalarial (Noreen et al., 2017) , anti-tubercular (Abid et al., 2020) , as anti-diabetic agents (Taha et al., 2020) , β-glucuronidase, (Lunagariya et al., 2019) , and urease inhibition (Filler et al., 2009) activities. While some natural alkaloids having indole also showed biological potential . Fluorine substituted compounds reported to have great industrial attraction in the past years (Zhou et al., 2016; Ilardi et al., 2014) . Effective synthetic methods established to spot fluorine on a heterocyclic ring while the manufacturing of fluorine containing compounds to target for possible therapeutic uses (Bukhari et al., 2015; Zhou et al., 2012) . The binding affinity and structure of protein-drug complexes are critical for deciphering the molecular mechanism involved in drug development.

Additionally, the SARS-CoV-2 main protease (PDB ID: 6LU7) and bacterial peptidoglycan (PDB ID: 2MTZ) are key target for the development of anti-COVID-19 and antibacterial drugs.

Moreover, the development of new antiviral or antibacterial drugs is not an easy task, as it required intensive time, labors and funds. Consequently, an alternative and non-traditional strategies are desirable to identify and develop new class of compounds that only not control infections but also overcome antibiotics resistance developed by a variety of pathogenic bacteria and viruses. Therefore, the designing and development of new class of broad-spectrum antimicrobial and antiviral compounds with reduced toxicity and higher specificity is of great interest for the academician, researchers and pharmaceutical industries. The objective of present study was (i) synthesis of indole-based-oxadiazole (1A-17A) compounds, (ii) Characterization of synthesized compounds by different sophisticated spectroscopic techniques such 1H NMR, 13C NMR, EI-MS, HREI-MS, and IR spectroscopy, (iii) investigation of their broad-spectrum antibacterial activity against gram-negative MDR-PA and gram-positive MRSA bacterial strains, (iv) investigation of antibiofilm potential of synthesized compounds against MDR-PA and MRSA, (v) interaction of top ranked compounds with bacterial peptidoglycan (PDB ID: 2MTZ) using molecular docking analysis, and (vi) molecular docking and in silico ADME/Tox profile analysis of the synthesized compounds with SARS CoV-2 main protease (3CLpro).

The 1H-NMR and 13C-NMR experiments were carried out using an Avance Bruker 300

MHz. HR-MS was determined in positive/negative mode on an Agilent 6330 Ion Trap. The Perkinelmer instrument was used to do the element analysis. Stuart (SMP-10) melting point device was used to record the melting point. Thin layer chromatography (TLC) was carried out using pre-coated silica gel aluminum foils (Germany). Chromatograms at 254 and 365 nm were seen using a UV light.

The 5-fluoroindoline-2-carbohydrazide was made by combining 25 mmol methyl 5-fluoro-1Hindole-2-carboxylate with 10 mL hydrazine hydrate in 50 mL methanol for 6 h. The solvent was evaporated once the reaction was completed, and the crude product was washed with cold water before being recrystallized in methanol.

In POCl3 (10 mL), a combination of 5-fluoro-1H-indole-2-carbohydrazide (0.3 mmol) and

various (1-17) aromatic acids (0.33 mmol) was refluxed for 4-6 h. The mixture was allowed to cool before being added to cold water. To eliminate the HCl created during the reaction, the mixture was reacted with NaHCO3. The ppt formed was filtered, dried, and crystallized in methanolic solution. 

Yield: (81%); 1 HNMR (300 MHz, DMSO-d6): 

Yield: ( 

Yield: (85%); 1 HNMR (300 MHz, DMSO-d6): 

Yield: ( 

The present investigation examined the antibacterial and antibiofilm activities of compounds A1-A17 against gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and gramnegative multidrug-resistant Pseudomonas aeruginosa strains. A single colony of fresh bacterial strain was grown overnight in Luria Bertani (LB) broth on a rotary shaker (200 rpm) at 37 °C. In the following step, the bacterial culture was washed with phosphate buffer saline, and the pellet was collected and re-suspended in fresh LB broth.

The MICs values of each compound were determined using serial two-fold microbroth dilution method in a 96 well polystyrene plates against MRSA and P. aeruginosa as protocol previously described [Ansari et al., 2021a] . The MIC is the lowest concentration of the investigated chemicals at which bacteria did not grow visibly.

Following the MIC analysis, an aliquots of 100 µl from wells with no visible bacterial growth (i.e., below MIC value) were inoculated on MHA plates for 24 h at 37 0 C. MBC was defined as the concentration that killed 99.99% of bacteria [Elsharif et al., 2019] .

The antibiofilm potential of each compound was quantitatively investigated against P. aeruginosa and MRSA strains by using microtitre culture plate assay [Baig et al., 2020] . Briefly, 20 µl fresh cultures of P. aeruginosa and MRSA strains (1x 10 7 CFU/ml) were added into 180 µl of increasing concentrations of each compound (0.25-4 mg/ml) in a 96 well sterile polystyrene flat bottom microtitre plate and were incubated without shaking at 37°C for 24 h. After 24 h of incubation, bacterial suspensions from each well were completely decanted and the wells were washed twice with sterile phosphate buffer saline (PBS, 1X) and left for complete air drying.

Each sample was then stained with 0.25% crystal violet solution for 30 min. Following staining, the wells were rinsed with PBS, the excess dyes were removed and then bound stain was solubilize with 95% ethanol. Finally, the absorbance was measured at 595 nm using a microtitre plate reader and percent biofilm inhibition was calculated by using following equation: (Wishart et al., 2007) and set as standards for the study. Furthermore, Discovery Studio visualizer 2020 (BIOVIA 2020) was used to complete the energy minimization process for the produced 3D structures of selected compounds using the CHARMM force field (Vanommeslaeghe et al., 2010) .

The 3D structure of bacterial peptidoglycan (PDB ID: 2MTZ) and SARS-CoV-2 main protease (PDB ID: 6LU7) was retrieved from Protein Data Bank ( (Berman et al., 2000; Ansari et al., 2021b; Jin et al., 2020; Rudrapal et al., 2022) . Then, for the energy reduction process, the CHARMM force field was applied to both 3D structures (Vanommeslaeghe et al., 2010) . For the aforementioned manipulation of 3D structures, Discovery Studio visualizer 2020 was employed (BIOVIA 2020).

We have utilized PyRx tool (Wolf 2009 ) which can perform major phases during molecular interaction like receptor and ligand molecules preparation, docking using AutoDock Vina tool (Trott and Olson 2010) . Initially, the PyRx tool was used to screen seventeen synthesized compounds (C1-C17) for their binding affinity against SARS-CoV2 (PDB ID: 6LU7). The PyRx tool generates interaction analysis results quickly (Wolf 2009; Dallakyan and Olson 2015) .

Based on the PyRx virtual screening and obtained MIC values of C1-C17 compounds against tested bacteria, compounds C6, C7, C8, C10 and C11 were chosen for docking studies with bacterial peptidoglycan and SARS-CoV2 Main Protease using the AutoDock tool. In order to cover the maximum area within the grid box of 60x60x60 Å that can accommodate the active site key residues His41,Cys145, and Glu166. Active site were identified and extracted through literature survey and form the PDB ID:6LU7 structure, the grid center point co-ordinates X, Y, and Z were set to -15.253, 14.22, 65.592 for PDB ID:6LU7 and 6.211, -5172, 12.171, respectively, for PDB ID:2MTZ (Entity3) (Jin et al., 2020; Zhang et al., 2020; Ansari et al., 2021b) .

The SwissADME online tool ( http://www.swissadme.ch) was used to determine the absorption, delivery, metabolism, and excretion (ADME), drug-likeness, and pharmacokinetics properties of compounds C6, C7, C8, C10, and C11 (Daina et al., 2017; Jamal et al., 2020 ) . Toxicity analysis was then carried out using the pkCSM online server http://biosig.unimelb.edu.au/pkcsm/), which can easily determine and predict the toxicity properties of compounds of interest (Pires et al., 2015) .

Target prediction is a potentially useful tool for identifying biological macromolecules such as proteins and enzymes in small drug-like compounds. We used free online Swiss Target Prediction to make this prediction (http://www.swisstargetprediction.ch) (Gfeller et al., 2014) .

The 5-fluoro-indole based oxadiazoles (1-17, Scheme 1) synthesized (Zawawi et al., 2015) . (Shirinzadeh et al., 2011; Zhang et al., 2013; Kandemir et al., 2014; Biernacki et al., 2020) .

In this present study, the antibacterial property of 5-fluoro-indole based oxadiazoles ( (Table 1) . It has been found that tested compounds were more effective against grampositive MRSA than gram-negative MDR-PA. These differences may be due to the structural differences in cell wall of these two types of bacteria. The cell wall of gram-positive bacteria i.e., MR-S. aureus has a single layer of peptidoglycans whereas gram-negative bacteria i.e., MDR-P. aeruginosa has multilayered cell wall, that possess an outer membrane, periplasmic space and lipopolysaccharides, which is absent in gram-positive bacteria. The resistance of gram-negative bacteria towards antibacterial agents due to their membranes being more lipophilic, which acts as a barrier for a variety of antimicrobial agents and thus hydrophilic substances were believed to be incapable of penetrating these bacteria's cell membranes. On the other hand, gram positive bacteria lack such an outer layer and an intricate cell wall structure and therefore, antibacterial agents are capable of easily destroying the gram-positive bacteria's cell wall and cytoplasmic membrane, resulting in the leakage of cytoplasm content that may led to the death of bacteria (Yao et al., 1999; Bala et al., 2014) .

MRSA and P. aeruginosa propensity to build biofilms is a critical virulence factor linked to nosocomial infections. These bacterial strains have the ability to form biofilm on a various surface especially on implanted medical devices such as mucus plugs, artificial implants, pacemakers, prosthetic joints, catheters, endotracheal tubes, intra-uterine devices, mechanical heart valves, tympanostomy tubes, urinary catheters, and voice prostheses and contact lenses (Zheng et al., 2018; Yamani et al., 2021) . Bacteria that colonize medical devices usually aggregate and grow in the form of biofilm. Biofilms are complex microbial communities that are encased in a matrix of extracellular polymeric substances, which are irreversibly attached to these surfaces. The structure and physiological features of a biofilm contribute to the characteristic resistance of biofilm-forming bacteria to antimicrobial agents, such as antibiotics or disinfectants. Importantly, biofilm also provide a shield from the biological attacks that occur in the form of host defenses (Zheng et al. 2018 ).

In the present study, antibiofilm activity of 1-17 was investigated against MRSA and MDR-P.

aeruginosa biofilms using crystal violet assay by measuring absorbance at 595 nm. Figure 1 and 2 clearly shows that tested compounds restrict biofilm formation in a dose-dependent manner.

A6, A7 and A11 showed maximum inhibition of biofilm formation by MRSA in compared to other tested compounds. It was found that at 4 mg/ml; A6, A7 and A11 inhibit MRSA biofilm formation by 81.1, 77.5 and 75.9%, respectively (Fig1); whereas in case of P. aeruginosa; A6 and A7 showed maximum biofilm inhibition and it was found that at 4 mg/ml, A6 and A7 inhibit biofilm formation by 81.5 and 73.7%, respectively (Fig. 2) . The Fig 1 and 2 clearly demonstrate that the A6, A7 and A11 suppressed MRSA biofilm formation more efficiently than the biofilm of P. aeruginosa. The plausible mechanism for interfering biofilm formation of MRSA and MDR-PA by tested compounds might be due to the disruption of adherence and colonization of bacterial cells.

The docking study was used to validate the antibacterial activity of selected compounds by investigating their binding affinity with bacterial peptidoglycans. Compounds A6, A7, A8, A10, and A11 were chosen for further deep analysis against bacterial peptidoglycan (PDB ID: 2MTZ, Entity ID 3) using the AutoDock tool, based on antibacterial activity (MIC values, Table 1 ). Not only does the cell wall protect the contents of the cell from adverse conditions, but it also provides rigidity, form, and, most significantly, specifies the cellular structure, which is critical for virulence and pathogenicity. The bacterial cell wall is composed of peptidoglycan, a longchain polymer of sugars and amino acids composed of alternating residues of -(1,4) linked Nacetylglucosamine (NAG) and N-acetylmuramic acid (NAM).

Based on our antibacterial findings (MIC), we used docking analysis to examine the binding affinity and possible interaction of compounds A6, A7, A8, A10, and A11 with bacterial peptidoglycan. The results of the docking studies of A6, A7, A8, A10, and A11 compounds with bacterial peptidoglycan (PDB ID: 2MTZ, Entity ID 3) and their binding affinities were shown in Table 3 and Figure 4 . Compounds A6, A7, A8, A10, and A11 had binding affinity ranging from -5.68 to -6.6 kcal/mol, indicating their high efficacy. The best inhibitor was the C8 molecule, which had the highest binding affinity of -6.6 kcal/mol and lowest inhibition Constant (Ki) of 14.60 µM. The A8 molecule formed 4 hydrogen bonds; 3 with N-acetylmuramic acid (i.e., AMU3, AMU5 and AMU5) and 1 with N-acetylglucosamine (NAG5) residues of peptidoglycan, respectively (Fig 4 and Table 3 ). On the other hand, compounds A6 and A10 formed 2 hydrogen bonds, while compound A7 and A11 formed 3 hydrogen bonds (Table 3 and Figure 4) , respectively, indicating that these interactions could be connected with damaging and irreversible conformational changes in the bacteria's cell wall structural proteins, which could result in the bacteria's death. Our findings imply that the synthesized compounds could be a good choice for antibiotic therapy and prevention of biofilm-related microbial infections.

A6, A7, A8, A10, and A11 were chosen for further deep analysis against main protease of SARS-CoV2 (PDB ID: 6LU7), using the AutoDock tool, based on their binding affinity (Kcal/mol) obtained by PyRx virtual screening tool (Table 2 ) and antibacterial activity results.

The molecular docking analysis was used to assess the anti-SARS-CoV2 efficacy of synthesized indole-based-oxadiazole derivatives by examining the binding modalities and orientation of the ligands in the receptor pocket of the main protease. The binding affinities of the synthesized compounds with the main protease were shown in Table 1 . The binding affinity of complexes was found to range between -6.75 and -7.78 kcal/mol, indicating their high potency. A6 and A11 were found to be the most effective inhibitors, with a binding affinity of -7.78 kcal/mol kcal/mol. Furthermore, the compounds studied in this work have a higher binding affinity than Remdesivir, a common antiviral medication with a binding affinity of − 6.41 kcal/mol (Table 4) . Waals (with Leu167, Ala191 and Gln 192) and carbon-hydrogen interaction (His164 and Gln189) was also observed (Fig 4 & table 4 ). Table 4 ).

In this study, the interaction energies examined by in silico analysis against major protease (PDB: 6LU7) with synthetic compounds (A6, A7, A8, A10, and A11) have a greater binding affinity (-6.75 to -7.78 kcal/mol) than conventional antiviral medicine Remdesivir, which has a binding affinity of -6.41 kcal/mol. Remdesivir has inhibition constant of 19.91 uM and formed five (5) with the length of 2.3, 2.2, 3.2, 3.2 and 3.07 Å, respectively. The amino acids involved in hydrophobic interaction were shown in Fig. 6 & Table 4 .

The number of hydrogen bonds and the distance between ligands and receptors have been demonstrated to be the most essential elements determining the binding affinity of a ligandreceptor interaction in numerous molecular docking studies (Elijah et al., 2020) . As a result, this reason explains why the designed molecule was able to bind tightly to the active pocket of the target enzyme. Overall, the findings of molecular docking interaction analysis revealed that His41, Cys145, and Glu166 amino acid residues were involved in a variety of interactions and bonding, including the formation of hydrogen bonds between selected compounds and the main protease. These amino acids contain the most important part of S1 pocket of main protease.

Glu166 mainly responsible for the maintenance of the S1 pocket's shape and stability after forming hydrogen bond and well supported by His41 and Cys145 (Zhang L 2020; Jamal 2021).

The antibacterial results encouraged us to undertake ADMET and drug-likeliness predictions of the active compounds i.e., A6, A7, A8, A10, and A11. It has been well-known that an inhibitor's antagonistic response to an enzyme or a protein receptor does not guarantee its suitability as a potential drug (Filler et al., 2009) . Therefore, ADMET, as well as drug-likeness analysis, are important in drug discovery, as they aid in making a rational decision on whether inhibitors can be administered to biological systems or not. Furthermore, inhibitors with low or poor ADME qualities, as well as severe toxicity effects on biological systems, are frequently the primary reason of failure medicines in clinical trials research.

ADME properties were tested based on several parameters like GI=Gastro intestinal absorption, BBB=Blood Brain Barrier, Pgp=P glycoprotein, CYP=Cytochrome, log Kp= skin permeation (Table 5) . SwissADME tool was utilized and resulting output suggested that compound A6, A7, A8, A10, and A11 have high GI absorption. Also, generated BOILED-Egg graph (Figure 7) shown that except A8 all selected compounds were found in yellow part in BOILED-Egg's yolk model which mean A6, A7, A10 and A11 are the compounds predicted to passively permeate through the blood-brain barrier (BBB). Further all compounds have Pgp substrate binding capability. As much as negative the log Kp value means that the molecule could be less skin permeant, therefore, all selected compounds A6, A7, A8, A10, and A11 have less skin permeability (Table 5) .

Drug-likeliness prediction provide another way for the analysis of the drug like behavior and physicochemical properties of selected compounds. All the compounds did not show Lipinski violations, Ghose violations, Veber violations and Egan violations. Topological polar surface area (TPSA), has been established as main parameter for the ADME properties assessment of the compounds in context with the BBB crossing TPSA value should be between 20 and 130 Å 2 (Ertl et al., 2000) . Compounds A6, A7, A8, A10, and A11 have TPSA values within the satisfactory range (Table) . SwissADME server output also provide a consensus log Po/w value, contain the arithmetic mean of Log Po/w (iLOGP), Log Po/w (XLOGP3), Log Po/w (WLOGP), Log Po/w (MLOGP) and Log Po/w (SILICOS-IT) (Daina 2016; Malik et al., 2021) . Consensus Log P value should not be higher than 6. Observed values of all selected compounds for this parameter were between 2.35 and 4.17 (Table 6) .

pkCSM server toxicity analysis results suggested that compound A7, A8, A10 and A11 not having AMES toxicity except A6, generally AMES toxicity analysis assess the mutagenic capability of chemical compounds. and only A10 and A11 shown hepatotoxicity. T. pyriformis toxicity values > 0.5 log ug/L will be considered as toxic properties of the compound. Selected compounds shown values between 0.289 and 0.301. Hence, observed results established compounds A6, A7, A8, A10, and A11 as a non-toxic. Further, no skin sensation was predicted for all compounds. Maximum tolerated dose (Human) should be <= 0.477 log (mg/kg/day).

Observed values for human dose parameter were ranged between 0.235-0.275 for A6, A7, A10 and A11, while it was higher for A8 with the value 0.814 (Table 7) .

SwissTargetPrediction is an online tool that predicts the macromolecular targets of bioactive small molecules (proteins from humans, mice, and rats). This is useful for deciphering the molecular pathways underlying a certain phenotypic or bioactivity, rationalizing potential side effects, predicting off-target effects, and evaluating the feasibility of repurposing therapeutically relevant molecules (Daina et al., 2017) . In the present study, the top 15 targets were selected for the A6, A7, A8, A10, and A11 from output data generated by SwissTarget server. It was found that A6 have 46.7% binding probability to interact with nuclear receptor types of biomolecules whereas A7 shown 33.3% interaction possibilities with protease and A8 have 40% binding capability with kinase while A10 and A11 shows 20% interaction with ligand gated ion channel and 13.3% with kinase, voltage gated ion channel, nuclear receptor, and protease. It was observed that A7 have maximum interaction probability with protease kind of biomolecules ( Figure 8 ).

In 

Emerging and re-emerging infectious diseases

Synthesis and characterization of the antibacterial potential of ZnO nanoparticles against extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated from a tertiary care hospital of North India

Gum arabic capped-silver nanoparticles inhibit biofilm formation by multi-drug resistant strains of Pseudomonas aeruginosa

A possible potential COVID-19 drug candidate

acetyl) hydrazono) malonate: Docking of disordered independent molecules of a novel crystal structure, HSA/DFT/XRD and cytotoxicity

Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities

Novel bis (1-acyl-2-pyrazolines) of potential antiinflammatory and molluscicidal properties

Biological activities of pyrazoline derivatives-A recent development. Recent patents on anti-infective drug discovery

Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents

Structural optimization of indole based compounds for highly promising anti-cancer activities: Structure activity relationship studies and identification of lead molecules

Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 6-methyl-4-[1-(2-substituted-phenylamino-acetyl)-1H-indol-3-yl]-2-oxo/thioxo-1, 2, 3, 4-tetrahydropyrimidine-5-carboxylic acid ethyl esters

Indole-3-ethylsulfamoylphenylacrylamides: potent histone deacetylase inhibitors with anti-inflammatory activity

Synthesis of 1-indolyl substituted β-carboline natural products and discovery of antimalarial and cytotoxic activities

Synthesis, antimicrobial, antimycobacterial and structure-activity relationship of substituted pyrazolo-, isoxazolo-, pyrimido-and mercaptopyrimidocyclohepta [b] indoles. European journal of medicinal chemistry

Synthesis of alpha amylase inhibitors based on privileged indole scaffold

Synthesis, βglucuronidase inhibition and molecular docking studies of cyano-substituted bisindole hydrazone hybrids

Synthesis of diindolylmethane (DIM) bearing thiadiazole derivatives as a potent urease inhibitor

Marine natural product bis-indole alkaloid caulerpin: Chemistry and biology. Mini reviews in medicinal chemistry

Fluorine in medicinal chemistry: a century of progress and a 60-year retrospective of selected highlights

Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade

Next generation of fluorine-containing pharmaceuticals, compounds currently in phase II-III clinical trials of major pharmaceutical companies: new structural trends and therapeutic areas

Data-mining for sulfur and fluorine: An evaluation of pharmaceuticals to reveal opportunities for drug design and discovery: Miniperspective

Synthesis, molecular modeling, and biological evaluation of novel 1, 3-diphenyl-2-propen-1-one based pyrazolines as anti-inflammatory agents

Recent researches in triazole compounds as medicinal drugs

Sol-Gel Synthesis of Dy-Substituted Ni0. 4Cu0. 2Zn0. 4 (Fe2-xDyx) O4 Nano Spinel Ferrites and Evaluation of Their Antibacterial, Antifungal, Antibiofilm and Anticancer Potentialities for Biomedical Application

DrugBank: a knowledgebase for drugs, drug actions and drug targets

The Protein Data Bank

New software and websites for the chemical enterprise

AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading

Synthesis of an activatable tetra-substituted nickel phthalocyanines-4 (3H)-quinazolinone conjugate and its antibacterial activity

Synthesis of cadmium sulfide-tungsten trioxide nanocomposites for photo-catalytic degradation of organic pollutants and growth retardation of waterborne bacteria and biofilms

CHARMM general force field: A force field for druglike molecules compatible with the CHARMM all-atom additive biological force fields

Green synthesis, antimicrobial, antibiofilm and antitumor activities of superparamagnetic γ-Fe2O3 NPs and their molecular docking study with cell wall mannoproteins and peptidoglycan

Structure of M pro from SARS-CoV-2 and discovery of its inhibitors

Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations

Small-molecule library screening by docking with PyRx

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved αketoamide inhibitors

SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

A Computational Study of Natural Compounds from Bacopa monnieri in the Treatment of Alzheimer's Disease

pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures

SwissTargetPrediction: a web server for target prediction of bioactive small molecules

Novel 2, 5-disubtituted-1, 3, 4-oxadiazoles with benzimidazole backbone: A new class of βglucuronidase inhibitors and in silico studies

Antimicrobial evaluation of indolecontaining hydrazone derivatives

Synthesis and antifungal activity of 3-(1, 3, 4-oxadiazol-5-yl)-indoles and 3-(1, 3, 4-oxadiazol-5-yl) methyl-indoles

Synthesis and biological evaluation of 2, 5-di (7-indolyl)-1, 3, 4-oxadiazoles, and 2-and 7-indolyl 2-(1, 3, 4-thiadiazolyl) ketones as antimicrobials

Novel 1, 2, 4-Oxadiazole Derivatives in Drug Discovery

Thickness and elasticity of gram-negative murein sacculi measured by atomic force microscopy

1, 3, 4-oxadiazole derivatives: synthesis, characterization, antimicrobial potential, and computational studies

Colonization of medical devices by staphylococci

Inverse correlation between biofilm production efficiency and antimicrobial resistance in clinical isolates of Pseudomonas aeruginosa. Microbial pathogenesis

Quantitative structure-activity relationship model, molecular docking simulation and computational design of some novel compounds against DNA gyrase receptor

Identification of doxorubicin as a potential therapeutic against SARS-CoV-2 (COVID-19) protease: a molecular docking and dynamics simulation studies

A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules

Molecular modelling assisted design of napthalimidedihydropyrimidinone conjugates as potential cytotoxic agents

Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties